Articles tagged with Research and Development Spending
The summit brought together endocrine leaders to identify opportunities to work closely together on increasing the visibility of endocrine health in policy decisions. Early findings from a workforce survey revealed challenges including long patient waiting times and retention concerns among early-career clinicians.
A comprehensive systematic review found that large-scale food fortification is a highly cost-effective intervention for reducing global malnutrition, with benefits far outweighing costs. The study analyzed 56 studies from 63 countries and found that fortification programs deliver substantial health benefits relative to costs.
A new report recommends increased investment in America's fusion diagnostic capabilities, a critical technology that could provide information to speed up the delivery of commercial fusion power plants. The report identifies key areas for research and development to advance U.S. leadership in fusion energy and plasma technologies.
The European Society of Endocrinology has released the EndoCompass Research Roadmap, a major new initiative to align research efforts and improve funding strategies for hormone-related health challenges. The roadmap identifies specific research needs across eight endocrine specialties and five cross-cutting areas.
A new study finds that over 50% of small-molecule drug patents this century are connected to NIH-backed research that would likely be cut under a 40% budget reduction. This highlights the significant impact of federally funded research on the development of life-changing medicines.
Between February and April 2025, 694 NIH grants were terminated across 24 institutes, affecting over $1.8 billion in funding. The terminations disproportionately impacted the National Institute on Minority Health and Health Disparities, accounting for 30% of all funding.
The American Association for the Advancement of Science (AAAS) CEO, Sudip S. Parikh, testified before the Senate Appropriations Committee about the importance of funding for biomedical research in America. He highlighted the risks of recent budget cuts and proposed budgets that could irreparably damage the nation's innovation ecosystem.
Research from Bentley University shows that biotechnology companies can maintain current levels of new drug approvals in face of global revenue reductions. Strategic distribution of cost reductions and continued investment in early-stage development by biotech firms sustain pipeline, contradicting industry claims.
A study found that distributing small amounts of funding to a large number of researchers generates more new results and innovations than concentrating funds on a few excellent researchers. Research funding above 50 million yen leads to stagnant results, highlighting the importance of efficient allocation strategies.
Researchers at SUNY Optometry aim to provide a deeper understanding of the biology of myopia, a leading cause of vision impairment worldwide. The study will investigate cellular and molecular mechanisms controlling eye growth and develop new treatments for refractive errors.
A new wiring diagram illustrates complex interactions between wheat traits to inform breeding decisions and future research. The tool shows connections among traits that may not have been apparent, serving as a decision support tool for crop scientists.
Researchers found that small groups of scientists are key in generating emerging topics in life sciences and medicine. The study analyzed PubMed data and author lists to identify past and current emerging keywords, revealing that smaller teams with fewer publications were crucial for generating high-performance keywords.